Healthcare
Live Price
Offline$12.01
-1.56% today
1Y Change
-64.93%
Window
Jun 20, 2025 โ Jun 12, 2026
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tonix Pharmaceuticals Holding Corp. (TNXP) is a Healthcare stock with a market cap of $190.00M and listed on NASDAQ. The stock last traded around $12.01 and down 64.9% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +29.8%, EPS growth of +91.7%, a dividend yield of 0.0%. What stands out right now is revenue +29.8%, EPS +91.7%, free cash flow -69.1% with operating margin -959.1% and ROIC -51.0%. Valuation already assumes a fairly strong business story at price/sales 14.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TNXP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TNXP
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TNXP Max Drawdown
-82.70%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for TNXP and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
โ
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.